
Vikas Dandekar
@vikasreports
Journalist - Indian pharma & healthcare. Views own
[email protected]
ID: 29193745
http://www.etprime.com 06-04-2009 12:53:34
30,30K Tweet
13,13K Followers
466 Following

#CornerOfficeConversation: #Cipla CEO, Umang Vohra on Innovation, Obesity Drugs, AI and more Vikas Dandekar | Anirban Chowdhury youtube.com/watch?v=-T9YEU…

The recipe that gave china the advantage in biotech Vikas Dandekar Rica BhattacharyyaET ETHealthWorld


The All India Institute of Medical Sciences (@AIIMS) is reeling under an acute shortage of staff, with 430 posts of doctors and 2,109 posts of faculty members lying vacant at the country’s premier medical institute. Ministry of Health



It starts: Eli Lilly launches #Mounjaro in India for obesity and type 2 diabetes treatment. Big market to tap. 100 million diabetes patients and an equal set of population with obesity. #weightloss #obesity Teena Thacker

.Eli Lilly and Co.’s global CEO David Ricks is spearheading the worldwide launch of popular diabetes & anti-obesity drugs #Mounjaro #Zepbound.The chief of $45-billion US-pharma giant spoke on a range of topics, from the next generation of weight loss drugs to trade barriers Vikas Dandekar


On his recent visit to India, Eli Lilly's Global CEO David Ricks spoke on a wide band of issues on our Economic Times The Morning Brief #podcast Teena Thacker ... thanks Anirban Chowdhury and his cracker team for this very important episode. open.spotify.com/episode/0u7OP4…

#ETMorningBriefPodcast: Corner Office Conversation with #EliLilly's Global CEO David Ricks | Listen in with Vikas Dandekar & Teena Thacker🎧 🎙️ economictimes.indiatimes.com/news/morning-b…


Indian drug makers like @DrReddy’s Labs, Zydus Lifesciences Ltd. and MSN Labs are setting up new manufacturing capacities as they race to launch copies of blockbuster anti-diabetes and weight-loss drugs #Wegovy & #Ozempic. Reporting with Vikas Dandekar


A new oral pill for weight loss has moved a step closer to commercial launch, raising hopes for those who suffer from “needle phobia” & have avoided taking Mounjaro/Wegovy, the two blockbusters. Oral drug-orforglipron, showed encouraging results in phase-III trials Vikas Dandekar


Data Fudging and the US FDA’s Rap on Raptim: Lessons Not Learnt #Pharma I #Drugs I #CRO I #Data I #Trials I #Data_integrity I #Violations I #Health I FDA I #NDA I #ANDAs I #IVPT_Study I Vikas Dandekar I #Ranbaxy Read more: pharma.economictimes.indiatimes.com/news/pharma-in…

Weight-loss medications like Mounjaro and Wegovy in India may lead to a decline in bariatric surgeries, say top doctors from reputed hospitals. But those who are morbidly obese may still need surgery. A well-balanced view from Economic Times search.app/fPj9QxQnmwjs4x…

Here Rica BhattacharyyaET covers an important angle that went largely untapped in India as fat busters are launched. Bariatric surgeries will be affected, experts say, but it is not the end of the road...Good read !!




#ETExclusive | ‘How did I miss it?’ #OmarAbdullah mocks Pak’s ‘Indus gold’ claim tinyl.co/3PPZ Omar Abdullah

#ETExclusive | Last time I was CM, my kids were in school’: Omar Abdullah on sons in the spotlight tinyl.co/3PPZ Omar Abdullah